摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

丁基-二甲基-膦 | 55482-34-3

中文名称
丁基-二甲基-膦
中文别名
——
英文名称
butyl-dimethyl-phosphine
英文别名
Butyl-dimethyl-phosphin;dimethylbutylphosphine;Dimethyl-n-butylphosphin;n-Butyldimethylphosphin;Butyldimethylphosphine;butyl(dimethyl)phosphane
丁基-二甲基-膦化学式
CAS
55482-34-3
化学式
C6H15P
mdl
——
分子量
118.159
InChiKey
AQFIDYYGNDVXHH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    69-70 °C(Press: 100 Torr)
  • 密度:
    0.8455 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    7
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • ANTIMICROBIAL CATIONIC POLYCARBONATES
    申请人:INTERNATIONAL BUSINESS MACHINES CORPORATION
    公开号:US20140301967A1
    公开(公告)日:2014-10-09
    Antimicrobial cationic polymers having one or two cationic polycarbonate chains were prepared by organocatalyzed ring opening polymerization. One antimicrobial cationic polymer has a polymer chain consisting essentially of cationic carbonate repeat units linked to one or two end groups. The end groups can comprise a covalently bound form of biologically active compound such as cholesterol. Other antimicrobial cationic polymers have a random copolycarbonate chain comprising a minor mole fraction of hydrophobic repeat units bearing a covalently bound form of a vitamin E and/or vitamin D2. The cationic polymers exhibit high activity and selectivity against Gram-negative and Gram-positive microbes and fungi.
    具有一个或两个阳离子聚碳酸酯链的抗菌阳离子聚合物是通过有机催化的环氧开聚合制备的。其中一种抗菌阳离子聚合物具有基本由阳离子碳酸酯重复单元构成的聚合物链,与一个或两个末端基团相连。末端基团可以包括胆固醇等生物活性化合物的共价结合形式。其他抗菌阳离子聚合物具有随机共聚碳酸酯链,其中含有少量疏水重复单元,带有维生素E和/或维生素D2的共价结合形式。这些阳离子聚合物对革兰氏阴性和革兰氏阳性微生物和真菌表现出高活性和选择性。
  • [EN] BRIDGED MACROCYCLIC COMPOUNDS AND PROCESSES FOR THE PREPARATION THEREOF<br/>[FR] COMPOSES MACROCYCLIQUES PONTES ET PROCEDES DE PREPARATION DESDITS COMPOSES
    申请人:ENANTA PHARM INC
    公开号:WO2005080408A1
    公开(公告)日:2005-09-01
    The present invention provides a method for preparing bridged macrocyclic compounds comprising the step of reacting a macrocyclic compound characterized by having at least two nucleophilic moieties with a bifunctional bridging reagent optionally in the presence of a catalyst, thereby producing a bridged macrocyclic product.
    本发明提供了一种制备桥联大环化合物的方法,包括以下步骤:将至少具有两个亲核基团的大环化合物与双功能桥接试剂反应,可选地在催化剂的存在下进行,从而产生桥联大环产物。
  • METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS
    申请人:MARUZEN PETROCHEMICAL CO., LTD.
    公开号:US20160108071A1
    公开(公告)日:2016-04-21
    The present invention provides a method for easily and inexpensively producing a heterogeneous catalyst used to synthesize a cyclic carbonate by reacting an epoxide with carbon dioxide and having excellent catalyst activity; a catalyst obtained using said manufacturing method; and a method for synthesizing a cyclic carbonate using said catalyst. A method for producing a catalyst that is used for the purpose of synthesizing a cyclic carbonate by subjecting to a reaction an epoxide with carbon dioxide, said method comprising the following steps (a) and (b): (a) a step of obtaining a catalyst precursor having a haloalkyl group or a haloaryl group by reacting a silane compound with a silica gel in the presence of xylene, the silane compound having a haloalkyl group or a haloaryl group and (b) a step of obtaining a catalyst for synthesizing a cyclic carbonate by reacting the catalyst precursor obtained in step (a) with a tertiary phosphine.
    本发明提供了一种用于通过将环氧化合物与二氧化碳反应来合成环状碳酸酯的异质催化剂的简便且廉价的生产方法;采用所述制备方法获得的催化剂;以及使用该催化剂合成环状碳酸酯的方法。用于生产一种用于合成环状碳酸酯的催化剂的方法,通过将环氧化合物与二氧化碳反应,该方法包括以下步骤(a)和(b):(a)通过在二甲苯存在下将硅烷化合物与二氧化硅反应以获得具有卤代烷基或卤代芳基的催化剂前驱体的步骤,其中所述硅烷化合物具有卤代烷基或卤代芳基;以及(b)通过将步骤(a)中获得的催化剂前驱体与三膦反应以获得用于合成环状碳酸酯的催化剂的步骤。
  • VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS
    申请人:INTERNATIONAL BUSINESS MACHINES CORPORATION
    公开号:US20180117162A1
    公开(公告)日:2018-05-03
    Gel-forming block copolymers were prepared comprising i) a central hydrophilic block consisting essentially of a divalent poly(ethylene oxide) chain and ii) two peripheral monocarbonate or polycarbonate hydrophobic blocks linked to the central block by linking groups bearing one or more hydrogen bond forming *—N(H)—* groups. The hydrophobic blocks comprise one or more vitamin-bearing subunits. The gel-forming block copolymers can be used to prepare various biodegradable and/or biocompatible hydrogel and organogel drug compositions, in particular antimicrobial and/or anti-tumor drug compositions. The hydrogel compositions have utility in depot injections for drug delivery. The hydrogen bonding *—N(H)—* group(s) provide longer in vivo lifetime of the hydrogel before degradation and a more prolonged and controlled release rate of a hydrophobic drug compared to similar hydrogels prepared from poly(ethylene glycol).
    制备了包含以下组成部分的凝胶形成嵌段共聚物:i)主要由二价聚乙二醇链组成的中心亲水性块和ii)通过带有一个或多个氢键形成*—N(H)—*基团连接到中心块的两个外周单碳酸酯或多碳酸酯疏水性块。疏水性块包含一个或多个含维生素的亚单位。这些凝胶形成嵌段共聚物可用于制备各种可生物降解和/或生物相容的水凝胶和有机凝胶药物组合物,特别是抗微生物和/或抗肿瘤药物组合物。水凝胶组合物在药物输送的库存注射中具有实用性。与由聚乙二醇制备的类似水凝胶相比,氢键*—N(H)—*基团提供了凝胶在体内降解之前更长的生命周期,以及与水凝胶相比更延长和控制释放速率的疏水性药物。
  • Selective Hydrogenation Catalyst and Methods of Making and Using Same
    申请人:Cheung Tin-Tack Peter
    公开号:US20100228065A1
    公开(公告)日:2010-09-09
    A composition comprising a supported hydrogenation catalyst comprising palladium and an organophosphorous compound, the supported hydrogenation catalyst being capable of selectively hydrogenating highly unsaturated hydrocarbons to unsaturated hydrocarbons. A method of making a selective hydrogenation catalyst comprising contacting a support with a palladium-containing compound to form a palladium supported composition, contacting the palladium supported composition with an organophosphorus compound to form a catalyst precursor, and reducing the catalyst precursor to form the catalyst. A method of selectively hydrogenating highly unsaturated hydrocarbons to an unsaturated hydrocarbon enriched composition comprising contacting a supported catalyst comprising palladium and an organophosphorous compound with a feed comprising highly unsaturated hydrocarbon under conditions suitable for hydrogenating at least a portion of the highly unsaturated hydrocarbon feed to form the unsaturated hydrocarbon enriched composition.
    一种包括支持的氢化催化剂的组合物,其中氢化催化剂包括钯和有机磷化合物,支持的氢化催化剂能够选择性地将高度不饱和烃氢化为不饱和烃。一种制备选择性氢化催化剂的方法,包括将支持物与含钯化合物接触以形成支持的钯组合物,将支持的钯组合物与有机磷化合物接触以形成催化剂前体,并还原催化剂前体以形成催化剂。一种将高度不饱和烃选择性氢化为富含不饱和烃的组合物的方法,包括将包括钯和有机磷化合物的支持催化剂与含高度不饱和烃的进料接触,在适宜的氢化条件下至少部分氢化高度不饱和烃进料以形成富含不饱和烃的组合物。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台